Skip to main content
. 2017 Mar 2;8(16):26896–26910. doi: 10.18632/oncotarget.15849

Figure 5. The fusion protein CysC-MpL inhibits intracellular DQ–collagen IV degradation by MCF10A neoT cells.

Figure 5

(A) Inhibition of intracellular DQ–collagen IV degradation by CysC-MpL as measured by flow cytometry. Flow cytometric data are presented as percentages of DQ–collagen IV degradation compared to the DMSO control. Error bars represent standard deviation of three replicates. Statistic indicator *P ≤ 0.05. (B) Inhibition of DQ–collagen IV degradation is represented by a shift in fluorescence intensity (thick line) as compared to the control MCF10A neoT cells treated with DMSO (thin line).